How can we detect potential cancer risks associated with commonly used medications? This study by Anton Pottegård and colleagues utilizes large-scale Danish health registry data to screen for possible drug-cancer associations. By examining thousands of drug-cancer pairs, the research highlights potential risks and identifies substances warranting further investigation. The findings offer a crucial tool for improving long-term drug safety and advancing cancer prevention efforts. This is precisely the process we are aiming at improving in terms of speed and width in use case 3 in the EVA project.
